Invention Grant
US08648072B2 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
有权
用于治疗代谢紊乱，包括肥胖和糖尿病的大麻素受体拮抗剂/反向激动剂
- Patent Title: Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
- Patent Title (中): 用于治疗代谢紊乱，包括肥胖和糖尿病的大麻素受体拮抗剂/反向激动剂
-
Application No.: US13537403Application Date: 2012-06-29
-
Publication No.: US08648072B2Publication Date: 2014-02-11
- Inventor: John F. McElroy , Robert J. Chorvat
- Applicant: John F. McElroy , Robert J. Chorvat
- Applicant Address: US DE Wilmington
- Assignee: Jenrin Discovery, Inc.
- Current Assignee: Jenrin Discovery, Inc.
- Current Assignee Address: US DE Wilmington
- Agency: Vance Intellectual Property PC
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D413/02 ; A61K31/415 ; C07D231/06 ; A61K31/4523 ; C07D401/02
Abstract:
The present invention provides novel pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers.
Public/Granted literature
Information query
IPC分类:
